397 related articles for article (PubMed ID: 15597353)
1. Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy.
Egan JA; Hay SN; Brecher ME
J Clin Apher; 2004; 19(4):165-7. PubMed ID: 15597353
[TBL] [Abstract][Full Text] [Related]
2. Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state.
Hay SN; Egan JA; Millward PA; Bandarenko N; Brecher ME
Ther Apher Dial; 2006 Jun; 10(3):237-41. PubMed ID: 16817787
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
Tuncer HH; Oster RA; Huang ST; Marques MB
Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
[TBL] [Abstract][Full Text] [Related]
5. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange.
Wyllie BF; Garg AX; Macnab J; Rock GA; Clark WF;
Br J Haematol; 2006 Jan; 132(2):204-9. PubMed ID: 16398654
[TBL] [Abstract][Full Text] [Related]
7. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
Bell WR; Braine HG; Ness PM; Kickler TS
N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
[TBL] [Abstract][Full Text] [Related]
8. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
Myers L
Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P; Remuzzi G
J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
Kakishita E
Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
[TBL] [Abstract][Full Text] [Related]
13. Morphologic diagnosis of thrombotic thrombocytopenic purpura.
Burns ER; Lou Y; Pathak A
Am J Hematol; 2004 Jan; 75(1):18-21. PubMed ID: 14695628
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
[TBL] [Abstract][Full Text] [Related]
15. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
[TBL] [Abstract][Full Text] [Related]
16. Plasma manipulation in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
Remuzzi G; Ruggenenti P
Ann Med Interne (Paris); 1992; 143 Suppl 1():19-26. PubMed ID: 1300882
[TBL] [Abstract][Full Text] [Related]
17. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura without schistocytes on the peripheral blood smear.
Daram SR; Philipneri M; Puri N; Bastani B
South Med J; 2005 Mar; 98(3):392-5. PubMed ID: 15813170
[TBL] [Abstract][Full Text] [Related]
19. Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.
Park YA; Waldrum MR; Marques MB
Am J Clin Pathol; 2010 Mar; 133(3):460-5. PubMed ID: 20154285
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
Bosch T; Wendler T
Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
